Total Payments
$1,602
2024 Payments
$212.95
Companies
5
Transactions
110
Medicare Patients
5,591
Medicare Billing
$884,131
Payment Breakdown by Category
Food & Beverage$1,602 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,602 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $803.85 | 50 | $0 (2024) |
| Allergan, Inc. | $666.03 | 54 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $45.93 | 3 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $45.05 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $40.97 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.95 | 10 | ABBVIE INC. ($212.95) |
| 2023 | $197.54 | 11 | AbbVie Inc. ($197.54) |
| 2022 | $205.56 | 14 | ABBVIE INC. ($186.39) |
| 2021 | $206.97 | 16 | AbbVie Inc. ($206.97) |
| 2020 | $191.69 | 15 | Allergan, Inc. ($169.89) |
| 2019 | $223.37 | 15 | Allergan Inc. ($150.50) |
| 2018 | $176.69 | 14 | Allergan Inc. ($176.69) |
| 2017 | $187.06 | 15 | Allergan Inc. ($168.95) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/15/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/10/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/12/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/03/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/03/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/09/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/29/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/08/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/15/2023 | AbbVie Inc. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/22/2023 | AbbVie Inc. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/05/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/01/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/10/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/27/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/20/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/23/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/04/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/06/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/27/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2022 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/25/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,176 | 2,992 | $844,650 | $222,389 |
| 2022 | 11 | 1,507 | 2,295 | $884,620 | $219,141 |
| 2021 | 10 | 1,282 | 1,953 | $759,885 | $194,941 |
| 2020 | 12 | 1,626 | 2,726 | $993,240 | $247,660 |
Total Patients
5,591
Total Services
9,966
Medicare Billing
$884,131
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 373 | 1,660 | $356,900 | $100,641 | 28.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 209 | 490 | $151,900 | $44,084 | 29.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 310 | 338 | $204,490 | $43,254 | 21.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 159 | 168 | $53,760 | $14,564 | 27.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 49 | 189 | $41,580 | $10,724 | 25.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 22 | 91 | $20,020 | $5,163 | 25.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,740 | $1,403 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 19 | $4,085 | $1,175 | 28.8% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $2,820 | $739.32 | 26.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,355 | $641.40 | 19.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 507 | 584 | $353,320 | $86,763 | 24.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 266 | 756 | $234,360 | $59,116 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 212 | 402 | $86,430 | $21,719 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 218 | 235 | $75,200 | $18,676 | 24.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 119 | 126 | $69,930 | $16,817 | 24.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 45 | 48 | $14,640 | $3,494 | 23.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 18 | $12,060 | $3,072 | 25.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 53 | 54 | $11,880 | $2,859 | 24.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $10,660 | $2,614 | 24.5% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 14 | 14 | $9,100 | $2,259 | 24.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 30 | 32 | $7,040 | $1,752 | 24.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 432 | 511 | $309,155 | $78,541 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 218 | 625 | $193,750 | $50,549 | 26.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 144 | 150 | $83,250 | $21,028 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 205 | 372 | $79,980 | $20,968 | 26.2% |
About Dr. Mohamed Abdel Khalek, M.D
Dr. Mohamed Abdel Khalek, M.D is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972687390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Abdel Khalek, M.D has received a total of $1,602 in payments from pharmaceutical and medical device companies, with $212.95 received in 2024. These payments were reported across 110 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($1,602).
As a Medicare-enrolled provider, Abdel Khalek has provided services to 5,591 Medicare beneficiaries, totaling 9,966 services with total Medicare billing of $884,131. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Roseburg, OR
- Active Since 10/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972687390
Products in Payments
- DALVANCE (Drug) $718.75
- TEFLARO (Drug) $429.79
- AVYCAZ (Drug) $321.34
- XIFAXAN (Drug) $45.05
- ZERBAXA (Drug) $33.04
- ELIQUIS (Drug) $21.80
- CAMZYOS (Drug) $19.17
- CUBICIN RF (Drug) $12.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseburg
William Townsend, Md, MD
Internal Medicine — Payments: $3,059
Internal Medicine $3,059
Lorrie Oksenholt, Do, DO
Internal Medicine — Payments: $1,576
Internal Medicine $1,576
Joel Lee, Md, MD
Internal Medicine — Payments: $1,275
Internal Medicine $1,275
Doru Totoian, Md, MD
Internal Medicine — Payments: $1,266
Internal Medicine $1,266
Dr. Hennie Abrio, Md, MD
Internal Medicine — Payments: $970.03
Internal Medicine $970.03
Dr. Mukesh Thawani, M.d, M.D
Internal Medicine — Payments: $834.34
Internal Medicine $834.34